422 related articles for article (PubMed ID: 16797490)
21. Activation of the tyrosinase gene promoter by neurofibromin.
Suzuki H; Takahashi K; Yasumoto K; Shibahara S
Biochem Biophys Res Commun; 1994 Dec; 205(3):1984-91. PubMed ID: 7811291
[TBL] [Abstract][Full Text] [Related]
22. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
[TBL] [Abstract][Full Text] [Related]
23. Recent insights into bone development, homeostasis, and repair in type 1 neurofibromatosis (NF1).
Schindeler A; Little DG
Bone; 2008 Apr; 42(4):616-22. PubMed ID: 18248783
[TBL] [Abstract][Full Text] [Related]
24. A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex.
Arun V; Wiley JC; Kaur H; Kaplan DR; Guha A
J Neurosci Res; 2013 Apr; 91(4):494-505. PubMed ID: 23361976
[TBL] [Abstract][Full Text] [Related]
25. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
[TBL] [Abstract][Full Text] [Related]
26. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1.
Jacks T; Shih TS; Schmitt EM; Bronson RT; Bernards A; Weinberg RA
Nat Genet; 1994 Jul; 7(3):353-61. PubMed ID: 7920653
[TBL] [Abstract][Full Text] [Related]
27. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
28. A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor.
Ratner N; Miller SJ
Nat Rev Cancer; 2015 May; 15(5):290-301. PubMed ID: 25877329
[TBL] [Abstract][Full Text] [Related]
29. Specific expression of the neurofibromatosis type 1 gene (NF1) in the hamster Schwann cell.
Nakamura T; Nemoto T; Arai M; Yamazaki Y; Kasuga T; Gutmann DH; Collins FS; Ishikawa T
Am J Pathol; 1994 Mar; 144(3):549-55. PubMed ID: 8129040
[TBL] [Abstract][Full Text] [Related]
30. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras.
Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A
Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337
[TBL] [Abstract][Full Text] [Related]
31. A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.
Güran S; Safali M
Cancer Genet Cytogenet; 2005 Jan; 156(1):86-8. PubMed ID: 15588864
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
[TBL] [Abstract][Full Text] [Related]
33. Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders.
Side L; Taylor B; Cayouette M; Conner E; Thompson P; Luce M; Shannon K
N Engl J Med; 1997 Jun; 336(24):1713-20. PubMed ID: 9180088
[TBL] [Abstract][Full Text] [Related]
34. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
[TBL] [Abstract][Full Text] [Related]
36. Neurofibromatosis 1: closing the GAP between mice and men.
Dasgupta B; Gutmann DH
Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
[TBL] [Abstract][Full Text] [Related]
37. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromatosis type 1 (NF1): diagnosis and management.
Ferner RE; Gutmann DH
Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
[TBL] [Abstract][Full Text] [Related]
39. The genetic and molecular pathogenesis of NF1 and NF2.
Yohay KH
Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]